Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Ruby Khatun Khatun
    Ruby Khatun Khatun
      • Home
      • Ruby Khatun Khatun

      Articles By : Ruby Khatun Khatun

      Unichem Labs gets 4 observations from USFDA for Roha facility

      Unichem Labs gets 4 observations from USFDA for Roha facility

      Ruby Khatun Khatun8 Aug 2018 10:30 AM IST
      New Delhi: Drug firm Unichem Laboratories said the US health regulator has made four observations after inspection of its active pharmaceutical...
      Regeneron to invest 100 million dollar in bluebird, jointly develop cancer therapies

      Regeneron to invest 100 million dollar in bluebird, jointly develop cancer therapies

      Ruby Khatun Khatun8 Aug 2018 10:00 AM IST
      Regeneron Pharmaceuticals Inc said it will invest $100 million in cancer drug developer bluebird bio Inc, and the companies will jointly develop new...
      Novo Nordisk expects lower US prices next year

      Novo Nordisk expects lower US prices next year

      Ruby Khatun Khatun8 Aug 2018 9:45 AM IST
      COPENHAGEN: Novo Nordisk, the world’s top maker of diabetes drugs, on Wednesday reported second-quarter operating profit broadly in line with...
      Scandal-hit Chinese vaccine maker Changsheng started falsifying records in 2014: Report

      Scandal-hit Chinese vaccine maker Changsheng started falsifying records in 2014: Report

      Ruby Khatun Khatun8 Aug 2018 9:30 AM IST
      SHANGHAI: Changsheng Biotechnology Co Ltd, a vaccine maker at the center of a safety scandal in China, began falsifying production records for its...
      Regulation of Oxytocin: Health Ministry holds video conference with States to discuss issues

      Regulation of Oxytocin: Health Ministry holds video conference with States to discuss issues

      Ruby Khatun Khatun7 Aug 2018 3:03 PM IST
      New Delhi: The Health Ministry yesterday held a video conference with the States/UTs on various issues relating to regulation of Oxytocin including...
      Sanofi launches multiple sclerosis drug in India

      Sanofi launches multiple sclerosis drug in India

      Ruby Khatun Khatun7 Aug 2018 10:30 AM IST
      Aubagio® offers patients diagnosed with Multiple Sclerosis the efficacy and convenience of once-a-day oral treatmentOver 200,000 people in India are...
      Alembic Pharma gets tentative USFDA approval for ophthalmic solution

      Alembic Pharma gets tentative USFDA approval for ophthalmic solution

      Ruby Khatun Khatun7 Aug 2018 10:15 AM IST
      New Delhi: Drug firm Alembic Pharmaceuticals has received tentative approval from the US Food and Drug Administration (USFDA) for Bimatoprost...
      Glenmark signs licence deal with Harbour BioMed to commercialise cancer antibody in Greater China

      Glenmark signs licence deal with Harbour BioMed to commercialise cancer antibody in Greater China

      Ruby Khatun Khatun7 Aug 2018 10:00 AM IST
      New Delhi: Glenmark Pharmaceuticals and biopharmaceutical firm Harbour BioMed have entered into an exclusive license agreement to develop, manufacture...
      More problems found in Chinese-made heart medications

      More problems found in Chinese-made heart medications

      Ruby Khatun Khatun7 Aug 2018 9:45 AM IST
      Shanghai: Two more Chinese drugmakers have announced that a blood-pressure medication they exported to Taiwan contained a potentially cancer-causing...
      Drug distributor Cardinals profit beats on pharma unit strength

      Drug distributor Cardinal's profit beats on pharma unit strength

      Ruby Khatun Khatun7 Aug 2018 9:30 AM IST
      U.S. drug distributor Cardinal Health Inc beat analyst estimates for adjusted fourth-quarter profit on Monday, supported by higher sales in its...
      After losing Fortis Bid, Manipal vyes to buy AMRI for upto Rs 1,000 crore

      After losing Fortis Bid, Manipal vyes to buy AMRI for upto Rs 1,000 crore

      Ruby Khatun Khatun6 Aug 2018 5:22 PM IST
      Mumbai: After losing the battle from IHH healthcare for Fortis Healthcare, Manipal Hospitals is now vying for AMRI Hospitals Ltd (Advanced Medical...
      Narcotics Bureau busts online pharmacy- Farma Glow for shipping illegal drugs

      Narcotics Bureau busts online pharmacy- Farma Glow for shipping illegal drugs

      Ruby Khatun Khatun6 Aug 2018 5:03 PM IST
      New Delhi: The NCB has busted an illegal Gurgaon-based online pharmacy that was allegedly shipping psychotropic medicinal tablets to the US and some...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok